Japan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid Arthritis
Clinical trial NCT03971253 · COMPLETED
Trial details
- NCT number
- NCT03971253
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-09-02
- Primary completion
- 2026-05-29
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.